FIRST MANHATTAN CO. LLC. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 66 filers reported holding VIKING THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,000
-25.0%
1,4000.0%0.00%
Q2 2022$4,000
+33.3%
1,400
+40.0%
0.00%
Q1 2022$3,000
-25.0%
1,0000.0%0.00%
Q4 2021$4,000
-33.3%
1,0000.0%0.00%
Q3 2021$6,000
+20.0%
1,0000.0%0.00%
Q2 2021$5,000
-99.9%
1,000
-99.5%
0.00%
-100.0%
Q3 2018$3,516,000
-30.7%
201,853
-62.3%
0.02%
-34.5%
Q2 2018$5,074,000
+177.4%
534,753
+27.7%
0.03%
+190.0%
Q1 2018$1,829,000418,7530.01%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders